Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 322

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients

Cohen, Pascal, Pagnoux, Christian, Mahr, Alfred, Arène, Jean‐Pierre, Mouthon, Luc, Le Guern, Véronique, André, Marie‐Hélène, Gayraud, Martine, Jayne, David, Blöckmans, Daniel, Cordier, Jean‐franÇois, Guillevin, Loïc, The French Vasculitis Study Group·2007·Arthritis Care & Research

Abstract

Objective: To compare long and short durations of adjunctive cyclophosphamide for the treatment of severe Churg‐Strauss syndrome (CSS). Methods: In this prospective multicenter therapeutic trial, 48 patients with CSS with at least 1 poor‐prognosis factor at baseline were treated with glucocorticoids and either 12 or 6 intravenous cyclophosphamide pulses. Results: At 8 years, complete remission rates and severe side effects of therapy were comparable for both groups. The overall difference in relapses was not significant between the 12‐pulse and the 6‐pulse regimens (P= 0.07), but when considering only the number of mild relapses this difference became statistically significant (P< 0.02). Although the total number of inclusions was not reached, the study was stopped prematurely in response to the superiority of the 12‐pulse regimen. Conclusion: We concluded that 12 cyclophosphamide pulses were better able to control severe CSS than a 6‐pulse regimen. The optimal duration of therapy remains to be determined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.22679

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 322

Metadata

Authors
Cohen, P., Pagnoux, C., Mahr, A., Arène, J., Mouthon, L., Le Guern, V., André, M., Gayraud, M., Jayne, D., Blöckmans, D., Cordier, J., Guillevin, L., & The French Vasculitis Study Group
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2007-04-30
Volume
57
Issue
4
Pages
686-693
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W2079613972
Cited by
322
References
23
FWCI
11.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients. https://app.cochat.ai/papers/10.1002/art.22679
The paper
Cohen, P., Pagnoux, C., Mahr, A., Arène, J., Mouthon, L., Le Guern, V., André, M., Gayraud, M., Jayne, D., Blöckmans, D., Cordier, J., Guillevin, L., & The French Vasculitis Study Group. (2007). Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients. Arthritis Care & Research. https://doi.org/10.1002/art.22679

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.